JNJ-61393215

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for JNJ-61393215, covering 2022-09-29 to 2025-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-61393215 in Healthy Japanese Male Participants [Phase 1]